The role of the porcine von Willebrand factor: baboon platelet interactions in pulmonary xenotransplantation

• Published in: Transplantation Vol. 74; no. 11; p. 1596
• Main Authors: Gaca, Jeffrey G, Lesher, Aaron, Aksoy, Olcay, Ruggeri, Zaverio M, Parker, William, Davis, R Duane
• Format: Journal Article
• Language: English
• Published: United States 15.12.2002
• Subjects: Animals; Antibodies, Monoclonal - pharmacology; Blood Platelets - physiology; Dimerization; Disseminated Intravascular Coagulation - etiology; Disseminated Intravascular Coagulation - physiopathology; Fibrin Fibrinogen Degradation Products - antagonists & inhibitors; Fibrin Fibrinogen Degradation Products - metabolism; Humans; Lung - physiopathology; Lung Transplantation - adverse effects; Mice; Papio - physiology; Platelet Aggregation - drug effects; Platelet Aggregation - physiology; Platelet Glycoprotein GPIb-IX Complex - immunology; Platelet Glycoprotein GPIb-IX Complex - physiology; Swine - physiology; Transplantation, Heterologous - adverse effects; von Willebrand Factor - physiology
• ISSN: 0041-1337
• DOI: 10.1097/00007890-200212150-00018

Porcine von Willebrand factor (pvWF) has been shown to bind to human glycoprotein Ib (GPIb) and cause activation of human (or primate) platelets in the absence of shear stress. Pulmonary xenografts develop disseminated intravascular coagulation (DIC) and microvascular thrombosis within hours of reperfusion, and the aberrant interaction between pvWF and human platelets may be a possible cause of xenograft-associated DIC. Experimental baboons (n=3) received mouse anti-human GPIb monoclonal antibody before undergoing orthotopic pulmonary xenotransplantation with porcine lungs expressing human membrane cofactor protein (CD46). Blocking the pvWF-GPIb interaction with a monoclonal antibody to GPIb prevented the agglutination of human and baboon platelets by pvWF in vitro. In vivo, the anti-GPIb antibody prevented platelet deposition and prevented the increases in D-Dimers (P=0.011) seen in control xenograft recipients (n=5). However, there was no difference in elevations of prothrombin times (PT) or improvement in the vasoconstriction associated with the loss of xenograft function. This study indicates that the DIC associated with the hyperacute dysfunction of pulmonary xenografts is a complex phenomenon that is affected by, but not solely dependent on, activation of platelets. Aberrant interactions between pvWF and GPIb play a significant role in DIC associated with pulmonary xenotransplantation.